Coronavirus Disease 2019 (COVID-19)

Frequently Asked Patient Questions

Bako Diagnostics provides the healthcare industry with a highly accurate antibody test to detect exposure to COVID-19.

This page offers answers to frequently asked patient questions. You can also view our Fact Sheet for Patients.

BakoID COVID-19 Antibody (Serology) Test

The antibody test used by Bako Diagnostics (BakoID COVID Antibody) is a blood test designed to detect immunoglobulin G (IgG) antibodies. The results indicate whether the body has been exposed to coronavirus disease 2019 (COVID-19), the disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The test may indicate whether the infection may be resolved, or is still resolving and/or whether the person has potential protection against re-infection (“protective immunity”).

Visit the CDC website for more information.

If result is POSITIVE, antibodies that likely resulted from a previous infection with SARS-CoV-2, or possibly a related coronavirus were detected.

If result is EQUIVOCAL, a secure evaluation is not possible (IgG was detected at a level or close to the threshold of the limit of detection for the test) and it is recommended the patient be re-drawn one to two weeks later and re-tested with the BakoID COVID Antibody test.

If result is NEGATIVE, the test did not detect the presence of antibodies.

Note that antibody (serology) tests may detect IgG antibodies from previous exposure to coronaviruses other than SARS-CoV-2. This can cause a false positive result.

If you have any reason to suspect you have been exposed to COVID-19 or have had symptoms in the past, you may be a good candidate for the antibody test. You must not be experiencing symptoms consistent with COVID-19 for at least seven days prior to testing. It’s important to contact a healthcare provider for guidance on where to get tested in your community.

It is currently unclear how SARS-CoV-2 antibodies respond over time, or whether individuals with COVID-19 antibodies are less susceptible to future infection. A negative result does not rule out SARS-CoV-2 infection and a follow up molecular (RT-PCR) diagnostic test should be considered to rule out infection.

BakoDx does not collect COVID-19 test specimens at the lab, we only perform the test on specimens collected by a healthcare provider.

Patients: Please do not go to the BakoDx lab for COVID-19 testing. Contact a healthcare provider for testing services. BakoDx will process the specimens collected by your clinician.

Results provide information that can help your healthcare provider make informed recommendations about your care.

No. The antibody test determines whether the body has been exposed and is producing an immune cell in response to COVID-19. A COVID-19 RNA virus test (BakoID COVID Viral test) will be able to determine if a person currently has the virus.

If it is determined that COVID Antibody testing is needed, your healthcare provider will draw a blood sample. Your sample will then be sent to a lab, such as BakoDx, for testing.

Your test results will be sent to your ordering facility.

Turnaround time for COVID Antibody testing results is typically 2-3 days from the time the specimen arrives at our laboratory, but due to the high demand, this may vary.

No. If you suspect you have been exposed to COVID-19, contact a healthcare provider. If testing is right for you, your doctor will direct you where to go to be tested.

Yes. The BakoID COVID Antibody test is available to healthcare partners. Call us at 1-855-422-5628 or use our contact us form.

Yes, BakoDx is a biosafety level 2 laboratory and follows strict personal and environmental hygiene protocols, which have been further strengthened and reinforced with all employees since the early days of the COVID-19 outbreak. BakoDx is a national, CLIA licensed, CAP accredited, innovative laboratory that offers molecular and anatomic pathology, and microbiology services.

COVID-19 Antibody Test Statements:

This test has been authorized by the U.S. Food and Drug Administration (FDA) under an emergency use authorization (EUA) for use by authorized laboratories, such as BakoDx.

This test has not been reviewed by the FDA.

This test has been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogen.

This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.

Negative results do not rule out SARS-CoV-2 infection, particularly in those who have been in contact with the virus. Follow-up testing with a molecular diagnostic should be considered to rule out infection in these individuals.

Results from antibody testing should not be used as the sole basis to diagnose or exclude SARS-CoV-2 infection or to inform infection status.

Positive results may be due to past or present infection with non-SARS-CoV-2 coronavirus strains, such as coronavirus HKU1, NL63, OC43, or 229E.